Dr. Noa G. Holtzman, MD

Dr. Holtzman practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Holtzman's NPI, 1235472002, was assigned on March 31, 2013. Dr. Holtzman graduated from Sidney Kimmel Medical College in 2013. Dr. Holtzman holds Florida license ME161711.

Dr. Holtzman's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Holtzman's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holtzman practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Holtzman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Holtzman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Holtzman's licenses on file in 2 states: Florida and Maryland.

CMS data shows 80 Medicare services from Dr. Holtzman across 1 procedure code in 2024, for 31 Medicare patients. Medicare paid $7,777 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Holtzman in 2024. The largest group is 65 to 74, with 16 patients. 74% of them have high blood pressure, and 68% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holtzman's median patient age at 64, with 41% women.

In 2024, Dr. Holtzman wrote 37 Medicare Part D claims. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $83 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Holtzman for performance year 2024, reported as part of a group. Dr. Holtzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holtzman as offering telehealth.

Dmand AI links 54 papers to Dr. Holtzman, published from 2015 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Graft vs Host Disease, Hematopoietic Stem Cell Transplantation and Immunotherapy, Adoptive. Dr. Holtzman has published most often in Blood Adv. Dr. Holtzman's most frequent co-authors are Ashkan Emadi, MD, PhD, Aaron Paul Rapoport, MD and Edward West Cowen, MD.

CMS Open Payments shows 9 general payments to Dr. Holtzman from 1 drug or device company in 2025. Travel and lodging make up the largest share, 81% of the total. National Marrow Donor Program paid the most, $2,144. It also lists 1 research payment totaling $1,250 in 2025, naming 1 clinical trial.

Dr. Holtzman graduated from Sidney Kimmel Medical College in 2013.

Dr. Holtzman is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.